PURPOSE. To determine the extent to which each layer of the mouse cornea di
splays alloimmunogenicity or immune privilege.
METHODS. Intact corneas or individual or combined layers of corneas from no
rmal or cauterized eyes of BALB/c. C57BL/b, and CD95L-deficient B6-gld mice
were grafted beneath the kidney capsule of normal BALB/c, B10.D2, BALB.B m
ice or of BALB/c mice presensitized to donor antigens. Graft fate was asses
sed clinically and histologically and acquisition of donor-specific delayed
hypersensitivity (DH) was assessed at selected intervals after grafting.
RESULTS. Full-thickness allogeneic corneas induced vigorous DH and were rej
ected acutely. Similar results were obtained with allografts of corneal epi
thelium alone (if supported by syngeneic viable stroma), allografts of epit
helium from cauterized corneas (containing Langerhans' cells), and stromal
allografts deprived of endothelium. Grafts comprised of stroma plus endothe
lium (without epithelium) were not rejected, nor did they induce DH unless
the graft had no CD95L expression. if stroma- endothelium grafts had no CD9
5L expression, DH directed against major histocompatibility complex (MHC),
but not minor histocompatibility, alloantigens was induced. Moreover, CD95L
expressed on stroma- endothelium grafts protected endothelial cells, but n
ot stromal cells, from rejection in presensitized recipients.
CONCLUSIONS. When grafted to a heterotopic site, the alloimmunogenicity of
the normal cornea resides within its epithelial and stromal layers, whereas
immune privilege arises from the endothelium. In normal mice, CD95L-expres
sing endothelium can inhibit the stroma from inducing immunity directed at
MHC alloantigens, but in presensitized mice the endothelium can protect its
elf only from immune rejection.